[ Tue, Oct 01st 2024 ]: WOPRAI
[ Tue, Oct 01st 2024 ]: WOPRAI
[ Tue, Oct 01st 2024 ]: WOPRAI
[ Tue, Oct 01st 2024 ]: WOPRAI
[ Tue, Oct 01st 2024 ]: WOPRAI
[ Tue, Oct 01st 2024 ]: WOPRAI
[ Tue, Oct 01st 2024 ]: WOPRAI
[ Tue, Oct 01st 2024 ]: WOPRAI
[ Tue, Oct 01st 2024 ]: WOPRAI
[ Tue, Oct 01st 2024 ]: WOPRAI
[ Tue, Oct 01st 2024 ]: WOPRAI
[ Tue, Oct 01st 2024 ]: WOPRAI
[ Tue, Oct 01st 2024 ]: WOPRAI
[ Tue, Oct 01st 2024 ]: WOPRAI
[ Tue, Oct 01st 2024 ]: WOPRAI
[ Tue, Oct 01st 2024 ]: WOPRAI
[ Tue, Oct 01st 2024 ]: WOPRAI
[ Tue, Oct 01st 2024 ]: WOPRAI
[ Tue, Oct 01st 2024 ]: WOPRAI
[ Tue, Oct 01st 2024 ]: WOPRAI
[ Tue, Oct 01st 2024 ]: WOPRAI
[ Tue, Oct 01st 2024 ]: WOPRAI
[ Tue, Oct 01st 2024 ]: WOPRAI
[ Tue, Oct 01st 2024 ]: WOPRAI
[ Tue, Oct 01st 2024 ]: WOPRAI
[ Tue, Oct 01st 2024 ]: WOPRAI
[ Tue, Oct 01st 2024 ]: WOPRAI
[ Tue, Oct 01st 2024 ]: WOPRAI
[ Tue, Oct 01st 2024 ]: WOPRAI
[ Tue, Oct 01st 2024 ]: WOPRAI
[ Tue, Oct 01st 2024 ]: WOPRAI
[ Tue, Oct 01st 2024 ]: WOPRAI
[ Tue, Oct 01st 2024 ]: WOPRAI
[ Tue, Oct 01st 2024 ]: WOPRAI
[ Tue, Oct 01st 2024 ]: WOPRAI
[ Tue, Oct 01st 2024 ]: WOPRAI
[ Tue, Oct 01st 2024 ]: WOPRAI
[ Tue, Oct 01st 2024 ]: WOPRAI
[ Tue, Oct 01st 2024 ]: WOPRAI
[ Tue, Oct 01st 2024 ]: WOPRAI
[ Tue, Oct 01st 2024 ]: WOPRAI
[ Tue, Oct 01st 2024 ]: WOPRAI
[ Tue, Oct 01st 2024 ]: WOPRAI
[ Tue, Oct 01st 2024 ]: WOPRAI
[ Tue, Oct 01st 2024 ]: WOPRAI
[ Tue, Oct 01st 2024 ]: WOPRAI
[ Tue, Oct 01st 2024 ]: WOPRAI
[ Tue, Oct 01st 2024 ]: WOPRAI
Robert Wasserman Reiterated (ANEB) at Buy and Held Target at $8 on, Oct 1st, 2024
- 🞛 This publication is a summary or evaluation of another publication
Robert Wasserman of Benchmark, Reiterated "Anebulo Pharmaceuticals, Inc." (ANEB) at Buy and Held Target at $8 on, Oct 1st, 2024.
Robert, nor any peers, have made any analyst calls on ANEB in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30